Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PDSB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 17
51 filers reported a long position in PDSB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.5M | 1.7M | +4.2% |
| Focus Partners Wealth | $565.8K | 642.2K | New |
| Quantinno Capital Management LP | $565.8K | 642.2K | New |
| BlackRock, Inc. | $535.4K | 607.6K | +9.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $517.4K | 587.1K | -11.1% |
| VANGUARD FIDUCIARY TRUST CO | $314.6K | 357.1K | +16.2% |
| Militia Capital Management LLC | $292.3K | 331.8K | New |
| CITADEL ADVISORS LLC | $285.3K | 323.8K | New |
| MORGAN STANLEY | $276.6K | 313.9K | +7,904.1% |
| BLAIR WILLIAM & CO/IL | $264.3K | 300K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.